Los Alamitos, CANCT07824622Now EnrollingIRB Ready

Human Metapneumovirus Infection Clinical Trial in Los Alamitos, CA

Access cutting-edge human metapneumovirus infection treatment through this phase 1 clinical trial at a research site in Los Alamitos. Study-provided care at no cost to qualified participants.

Sponsored by AstraZeneca

Quick Self-Assessment

See if you qualify for this Los Alamitos location

Preparing your pre-screening questions…

Expert Care in Los Alamitos

Access human metapneumovirus infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related human metapneumovirus infection treatment provided free

Apply for This Los Alamitos Location

Check if you qualify for this human metapneumovirus infection clinical trial in Los Alamitos, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Alamitos

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Alamitos site if eligible
  4. 4Begin participation

About This Human Metapneumovirus Infection Study in Los Alamitos

The purpose of this study is to assess the safety and PK of AZD0543 compared to placebo in healthy adults 18 to 55 years of age. AZD0543 or placebo will be administered as single IM or IV dose. The study duration will be approximately 12 months for each participant following administration of IMP.

Sponsor: AstraZeneca

Who Can Participate

Inclusion Criteria

Age 18 to 55 years
Body weight ≥ 45 kg and ≤ 110 kg and BMI within the range ≥ 18.0 kg/m2 to ≤ 30 kg/m2 Key

Exclusion Criteria

Hypersensitivity to IMP/components
Severe adverse reaction/hypersensitivity to other mAbs
Acute fever/illness/infection within 3 days of planned dosing
Clinically important illness/procedure/trauma within 4 weeks of IMP administration
Active infection with Hepatitis B/C
Clinically significant bleeding disorders
Known/suspected immune deficiency/suppression
Receipt of blood products/immunoglobulins or immunosuppressive therapies within 6 months prior to screening (immunosuppressive medications/therapies include glucocorticoids exceeding 2 weeks of prednisone (or equivalent) 20mg daily or every other day)
Malignancy within previous 5 years; except treated non-melanoma skin cancers and locally treated cervical cancer
Receipt of any licensed/investigational hMPV vaccine, other therapies and procedures as applicable; participation in other clinical studies
Screening Abnormalities: clinically significant ECG, positive drug panel, Hgb/platelets/WBC outside of reference; all SCr/AST/ALT \> 1.5X ULN
Women who are pregnant, lactating, or of childbearing potential and not using a highly effective birth control method

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Alamitos?

Yes, this clinical trial (NCT07824622) has an active research site in Los Alamitos, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Human Metapneumovirus Infection Treatment Options in Los Alamitos, CA

If you're searching for human metapneumovirus infection treatment options in Los Alamitos, CA, this clinical trial (NCT07824622) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Alamitos research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced human metapneumovirus infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all human metapneumovirus infection clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Los Alamitos, CA

See all essential tremor clinical trials recruiting in Los Alamitos — not just this study.

Browse Essential Tremor Trials in Los Alamitos →

Browse More Trials by Condition

Essential Tremor TrialsPrurigo Nodularis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Los Alamitos?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Alamitos, CA